Lara Ajamian

618 citations
13 papers · 494 indexed · h-index 10
Topics
RNA Research and Splicing (8 papers)HIV Research and Treatment (7 papers)Viral Infections and Immunology Research (4 papers)
Partner nations
CanadaChileGermany

In The Last Decade

Lara Ajamian

13 papers receiving 489 citations

Peers

Lara Ajamian
Comparison fields: 5 of 43
  • Molecular Biology 376
  • Virology 165
  • Cardiology and Cardiovascular Medicine 107
  • Infectious Diseases 102
  • Immunology 86
Replace Shringar Rao with:
Shringar Rao Netherlands
Paulina S. Rubilar France
Yajuan Rui China
Xiao-Fang Yu United States
Rujun Song Canada
Kai Er Eng Sweden
Silas F. Johnson United States
Dylan Koundakjian United States
Allan Lau Canada
Maria Korom United States
Lara Ajamian relative to Shringar Rao Netherlands Shringar Rao's profile →
Citations per field
00.5×8.3×
Shringar Rao · 1×
Citations per year

Countries citing papers authored by Lara Ajamian

Since Specialization
Citations

This map shows the geographic impact of Lara Ajamian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Ajamian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Ajamian more than expected).

Fields of papers citing papers by Lara Ajamian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Ajamian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Ajamian. The network helps show where Lara Ajamian may publish in the future.

Co-authorship network of co-authors of Lara Ajamian

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Ajamian. A scholar is included among the top collaborators of Lara Ajamian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Ajamian. Lara Ajamian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 13
2 3
3 44
4 66
5 22
6 31
7 31
8 3
9 3
10 101
11 83
12 13
13 81

About Lara Ajamian

Lara Ajamian is a scholar working on Virology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 13 papers that have together received 494 indexed citations. Recurring topics across this work include RNA Research and Splicing (8 papers), HIV Research and Treatment (7 papers) and Viral Infections and Immunology Research (4 papers). The work is most often cited by research in Virology (165 citations), Infectious Diseases (102 citations) and Molecular Biology (376 citations). Lara Ajamian has collaborated with scholars based in Canada, Chile and Germany. Frequent co-authors include Andrew J. Mouland, Anne Monette, Miroslav P. Milev, Kishanda Vyboh, Marcelo López‐Lastra, Levon Abrahamyan, Andreas E. Kulozik, Niels H. Gehring, Fernando Valiente‐Echeverría and Pavel Ivanov. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026